Vizz, an aceclidine-based eye drop, is FDA-approved for presbyopia, enhancing near vision without myopic shifts. Successful Phase III trials showed Vizz's efficacy and safety, with near vision ...

Qlosi indicated for adult patients. Orasis Pharmaceuticals announced that the FDA has officially approved Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% for the treatment of Presbyopia in ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past efforts by other drug developers have mostly been unsuccessful. The ...

Millions of Britons could have an undiagnosed eye condition that experts say may be the cause of ‘resting squint face’. If someone narrows their eyes and furrows their brow while focusing on screens ...

Everybody develops presbyopia as they age – a difficulty in focusing on near objects and text – and often have to resort to reading glasses. However, the solution might be as simple as using special ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...